Ossium Health, Inc.
Indianapolis, IN
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- CD88LM1CK1A6
-
- SAM.gov registration date
- Physical address
- 5762 W 74th St, Indianapolis, IN 46278, USA
- Website
- ossiumhealth.com
- Founded
- 2016
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $48,891,921 |
| FY2025 | $0 |
| FY2024 | $21,043,426 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $48,891,921 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Bone marrow cryo-banking to treat acute radiation syndrome in a mass-casualty emergency | Office of the Assistant Secretary for Preparedness and Response | $69,935,347 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Ossium Health, Inc. is a for-profit biotechnology company headquartered in San Francisco, California, specializing in advanced biomedical research and cell-based therapeutic technologies. The company focuses on developing innovative solutions in stem cell transplantation, bone marrow banking, and medical countermeasures for radiation-related injuries. As a corporate entity registered in SAM.gov, Ossium Health provides sophisticated biomedical research and development services to federal agencies, particularly in the healthcare and medical research domains.
Through its federal contract awards, Ossium Health has secured a significant $124,993,937.09 cost-sharing definitive contract with the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The contract's primary objective is to develop a bone marrow cryogenic banking capability specifically designed to treat acute radiation syndrome in mass casualty emergency scenarios. The contract, awarded on August 9, 2024, with a completion date of July 31, 2029, was not set aside for any specific business type and represents a critical national preparedness initiative in medical emergency response.
Ossium Health has been awarded multiple federal grants from agencies like the National Institutes of Health, including the National Institute of Allergy and Infectious Diseases, the National Heart Lung and Blood Institute, and the National Institute of General Medical Sciences. These grants have supported diverse research projects, such as developing a bank of purified myeloid progenitor cells for radiation injury treatment, investigating mesenchymal stem cell transduction techniques, and creating innovative cell culture media filtration systems to reduce manufacturing costs. The grant awards, ranging from approximately $750,226 to smaller research grants, have consistently focused on advancing stem cell technologies, exploring cell manufacturing optimizations, and developing medical countermeasures for complex medical challenges, particularly those related to radiation exposure and cellular therapeutics.
Quick answers
Is Ossium Health, Inc. registered in SAM.gov?
Yes. Ossium Health, Inc.'s SAM.gov registration is active through January 28, 2027.
What is Ossium Health, Inc.'s CAGE code?
Ossium Health, Inc.'s CAGE code is 7QL09, and its Unique Entity ID (UEI) is FFNHJ2RDRHW3.
How much has Ossium Health, Inc. received in federal contracts?
Federal contracts obligated $69,935,347 to Ossium Health, Inc. in fiscal years 2023 through 2027.
What is Ossium Health, Inc.'s most recent federal award?
Ossium Health, Inc.'s most recent federal grant award is Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting… (R44AI183961), from National Institute of Allergy and Infectious Diseases (NIH), on August 14, 2024.
On GovTribe
See Ossium Health, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors